These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30530241)

  • 1. Harnessing CRISPR-Cas systems for precision engineering of designer probiotic lactobacilli.
    Goh YJ; Barrangou R
    Curr Opin Biotechnol; 2019 Apr; 56():163-171. PubMed ID: 30530241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing.
    Zuo F; Marcotte H
    Curr Opin Biotechnol; 2021 Aug; 70():75-82. PubMed ID: 33445135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portable CRISPR-Cas9
    Goh YJ; Barrangou R
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a RecE/T-Assisted CRISPR-Cas9 Toolbox for Lactobacillus.
    Huang H; Song X; Yang S
    Biotechnol J; 2019 Jul; 14(7):e1800690. PubMed ID: 30927506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-based engineering of next-generation lactic acid bacteria.
    Hidalgo-Cantabrana C; O'Flaherty S; Barrangou R
    Curr Opin Microbiol; 2017 Jun; 37():79-87. PubMed ID: 28622636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible Plasmid Self-Destruction (IPSD) Assisted Genome Engineering in Lactobacilli and Bifidobacteria.
    Zuo F; Zeng Z; Hammarström L; Marcotte H
    ACS Synth Biol; 2019 Aug; 8(8):1723-1729. PubMed ID: 31277549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining omics technologies with CRISPR-based genome editing to study food microbes.
    Pan M; Barrangou R
    Curr Opin Biotechnol; 2020 Feb; 61():198-208. PubMed ID: 32035346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing using the endogenous type I CRISPR-Cas system in
    Hidalgo-Cantabrana C; Goh YJ; Pan M; Sanozky-Dawes R; Barrangou R
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15774-15783. PubMed ID: 31341082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Editing with Cas9 in Lactobacilli.
    Vento JM; Beisel CL
    Methods Mol Biol; 2022; 2479():245-261. PubMed ID: 35583743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploiting heterologous and endogenous CRISPR-Cas systems for genome editing in the probiotic Clostridium butyricum.
    Zhou X; Wang X; Luo H; Wang Y; Wang Y; Tu T; Qin X; Su X; Bai Y; Yao B; Huang H; Zhang J
    Biotechnol Bioeng; 2021 Jul; 118(7):2448-2459. PubMed ID: 33719068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
    Naduthodi MIS; Barbosa MJ; van der Oost J
    Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
    Mojica FJM; Montoliu L
    Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing the Endogenous CRISPR-Cas9 System for High-Efficiency Genome Editing in
    Gu S; Zhang J; Li L; Zhong J
    ACS Synth Biol; 2022 Dec; 11(12):4031-4042. PubMed ID: 36414383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.